Evidence map›Paper›PMID 16118327›Full record

ArticleBlood2005

Bone marrow dysfunction in mice lacking the cytokine receptor gp130 in endothelial cells.

Longbiao Yao, Takafumi Yokota, Lijun Xia, Paul W Kincade, Rodger P McEver

Open access · greenAbstract read
In one paragraph

Article in Blood, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Gp130-HIF1α axis-induced vascular damage is prevented by the short-term inhibition of IL-6 receptor signaling.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  7. Review
  8. The vasculature niches required for hematopoiesis.Journal of molecular medicine (Berlin, Germany) · 2022
    Review
  9. Article
  10. Review
  11. Interactions of Hematopoietic Stem Cells with Bone Marrow Niche.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  12. Insights Into Bone Marrow Niche Stability: An Adhesion and Metabolism Route.Frontiers in cell and developmental biology · 2021
    Review
  13. Exosomes in the Healthy and Malignant Bone Marrow Microenvironment.Advances in experimental medicine and biology · 2021
    Article
  14. Review
  15. Hematopoiesis and Cardiovascular Disease.Circulation research · 2020
    Review
  16. Review
  17. Haematopoietic stem cell activity and interactions with the niche.Nature reviews. Molecular cell biology · 2019
    Review
  18. Review
  19. Extrinsic regulation of hematopoietic stem cells in development, homeostasis and diseases.Wiley interdisciplinary reviews. Developmental biology · 2017
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Longbiao YaoCardiovascular Biology Research Program, Oklahoma Medical Research Foundation, 825 NE 13th St, Oklahoma City, OK 73104, USA.
Takafumi Yokota
Lijun Xia
Paul W Kincade
Rodger P McEver
Oklahoma Medical Research Foundation · US

Funding

THROMBOSIS: ETIOLOGY, RISK FACTORS AND TREATMENTP50HL054502 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI MCEVER, RODGER PAUL · 1996 to 2005
$9.6M
EARLY EVENTS IN MAMMALIAN B-CELL DIFFERENTIATION.R01AI020069 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KINCADE, PAUL WAYNE · 1985 to 2012
$5.2M
MOLECULAR ASPECTS OF HUMAN LYMPHOPOIESISP01AI045864 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI THOMPSON, LINDA F. · 1999 to 2002
$2.5M
EARLY EVENTS IN MAMMALIAN B-CELL DIFFERENTIATIONR37AI020069 · NIAID · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI KINCADE, PAUL WAYNE · 1989 to 1996
–
NHLBI NIH HHS HL 54502NIAID NIH HHS AI 20069NIAID NIH HHS AI 45864
6 · The paper itself

Abstract

In vitro studies suggest that bone marrow endothelial cells contribute to multilineage hematopoiesis, but this function has not been studied in vivo. We used a Cre/loxP-mediated recombination to produce mice that lacked the cytokine receptor subunit gp130 in hematopoietic and endothelial cells. Although normal at birth, the mice developed bone marrow dysfunction that was accompanied by splenomegaly caused by extramedullary hematopoiesis. The hypocellular marrow contained myeloerythroid progenitors and functional repopulating stem cells. However, long-term bone marrow cultures produced few hematopoietic cells despite continued expression of gp130 in most stromal cells. Transplanting gp130-deficient bone marrow into irradiated wild-type mice conferred normal hematopoiesis, whereas transplanting wild-type bone marrow into irradiated gp130-deficient mice did not cure the hematopoietic defects. These data provide evidence that gp130 expression in the bone marrow microenvironment, most likely in endothelial cells, makes an important contribution to hematopoiesis.

Indexed as

AnimalsAnimals, NewbornBone MarrowBone Marrow TransplantationCell CountCell DifferentiationCells, CulturedCytokine Receptor gp130Endothelial CellsGenes, ReporterHematopoiesisMiceMice, TransgenicReceptor, TIE-2Survival RateTime FactorsCytokine Receptor gp130Receptor, TIE-2

Identifiers

PMID16118327
PMCPMC1895244
OpenAlexW2070554668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.